Article
New perspectives on the mutated NGLY1 enigma.
Medical hypotheses - 1 Nov 2015
Tickotsky-Moskovitz Nili
Abstract excerpt
The enzyme N-glycanase 1 (NGLY1) is considered a component of the endoplasmic reticulum-associated degradation (ERAD) machinery and clinical manifestations of its dysfunction include global developmental delay, a movement disorder, peripheral neuropathy, liver disorders, microcephaly, diminished reflexes and seizures. Although several mutations in NGLY1 have been identified, the relation between the defected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
